Cargando…

MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells

BACKGROUND: The MUC1-C protein evolved in mammals to protect barrier tissues from loss of homeostasis; however, MUC1-C promotes oncogenesis in association with chronic inflammation. Aberrant expression of MUC1-C in cancers has been linked to depletion and dysfunction of T cells in the tumor microenv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morimoto, Yoshihiro, Yamashita, Nami, Daimon, Tatsuaki, Hirose, Haruka, Yamano, Shizuka, Haratake, Naoki, Ishikawa, Satoshi, Bhattacharya, Atrayee, Fushimi, Atsushi, Ahmad, Rehan, Takahashi, Hidekazu, Dashevsky, Olga, Mitsiades, Constantine, Kufe, Donald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923360/ https://www.ncbi.nlm.nih.gov/pubmed/36754452 http://dx.doi.org/10.1136/jitc-2022-006238

Ejemplares similares

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells
por: Yamashita, Nami, et al.
Publicado: (2023)

MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression
por: Bhattacharya, Atrayee, et al.
Publicado: (2023)

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment
por: Morimoto, Yoshihiro, et al.
Publicado: (2022)

MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
por: Yamashita, Nami, et al.
Publicado: (2021)

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
por: Yamashita, Nami, et al.
Publicado: (2023)

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021)

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer
por: Fushimi, Atsushi, et al.
Publicado: (2022)

MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
por: Bhattacharya, Atrayee, et al.
Publicado: (2022)

Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer
por: Yamashita, Nami, et al.
Publicado: (2022)

MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer
por: Hagiwara, Masayuki, et al.
Publicado: (2022)

MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells
por: Hagiwara, Masayuki, et al.
Publicado: (2021)

MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?
por: Risti, Matilde, et al.
Publicado: (2017)

Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression
por: Yamashita, Nami, et al.
Publicado: (2022)

The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA
por: Isernhagen, Antje, et al.
Publicado: (2015)

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
por: Secchiari, Florencia, et al.
Publicado: (2022)

Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells
por: Weiss-Steider, Benny, et al.
Publicado: (2011)

MICA and NKG2D variants as risk factors in spondyloarthritis: a case–control study
por: Fechtenbaum, Marie, et al.
Publicado: (2018)

Tumor-Derived Soluble MICA Obstructs the NKG2D Pathway to Restrain NK Cytotoxicity
por: Luo, Qizhi, et al.
Publicado: (2020)

NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
por: Yan, Sen, et al.
Publicado: (2022)

Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
por: Alam, Maroof, et al.
Publicado: (2014)

MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells
por: Kosugi, Michio, et al.
Publicado: (2011)

MUC1-C ACTIVATES THE TAK1 INFLAMMATORY PATHWAY IN COLON CANCER
por: Takahashi, Hidekazu, et al.
Publicado: (2015)

The Impact of Glycosyl-Phosphatidyl-Inositol Anchored MICA Alleles on Novel NKG2D-Based Therapies
por: Valés-Gómez, Mar
Publicado: (2015)

Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer
por: Chen, Jiong, et al.
Publicado: (2015)

The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation
por: Isernhagen, Antje, et al.
Publicado: (2015)

Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells
por: Møller, Sofie H., et al.
Publicado: (2020)

Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia
por: Kufe, Donald W.
Publicado: (2022)

Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer
por: Kufe, Donald
Publicado: (2023)

COOPERATIVITY OF THE MUC1 ONCOPROTEIN AND STAT1 PATHWAY IN POOR PROGNOSIS HUMAN BREAST CANCER
por: Khodarev, Nikolai, et al.
Publicado: (2009)

MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks
por: Isernhagen, Antje, et al.
Publicado: (2016)

Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis
por: Wielińska, Joanna, et al.
Publicado: (2021)

NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cells
por: Xing, Samantha, et al.
Publicado: (2020)

MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA
por: Kim, Younghoon, et al.
Publicado: (2020)

MUC1-C drives DNA methylation in cancer
por: Rajabi, Hasan, et al.
Publicado: (2016)

NKG2D: A Master Regulator of Immune Cell Responsiveness
por: Wensveen, Felix M., et al.
Publicado: (2018)

The impact of NKG2A and NKG2D receptors and HLA-E and MICA ligands polymorphisms on post-transplant complications after paediatric allogeneic HSCT: a single-centre experience
por: Siemaszko, Jagoda, et al.
Publicado: (2023)

Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells
por: Kufe, Donald W.
Publicado: (2022)

Cell Surface Organization of Stress-inducible Proteins ULBP and MICA That Stimulate Human NK Cells and T Cells via NKG2D
por: Eleme, Konstantina, et al.
Publicado: (2004)

Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma
por: López-Cobo, Sheila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1on937tvaa1b36ga5cs4s5eenj